VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 101–200 of 1,013
Carnero, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941865 · Cited by 272
“The PI3K-AKT pathway is robustly activated by vascular endothelial growth factor (VEGF; reviewed in [79]), promoting endothelial cell survival, growth, and proliferation.”
BackgroundAngiogenic factors in bone local environment
Chim, S. M., Tickner, J., Chow, S. T., Kuek, V., Guo, B., Zhang, G., Rosen, V., Erber, W., & Xu, J. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.008 · Cited by 264
“activities [72–74].”
Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF–VEGFR-2 Signaling
Sison, K., Eremina, V., Baelde, H., Min, W., Hirashima, M., Fantus, I. G., & Quaggin, S. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030295 · Cited by 268
Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7
Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802857105 · Cited by 268
“Prior studies have implicated MEF2 in the control of EC survival downstream of the MAPK pathway (34, 35).”
BackgroundInfluentialVEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267
Spatial regulation of VEGF receptor endocytosis in angiogenesis
Nakayama, M., Nakayama, A., van Lessen, M., Yamamoto, H., Hoffmann, S., Drexler, H. C. A., Itoh, N., Hirose, T., Breier, G., Vestweber, D., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2679 · Cited by 260
Takahashi, S. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1785 · Cited by 261
Roskoski, R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.010 · Cited by 260
VEGF may contribute to macrophage recruitment and M2 polarization in the decidua
Wheeler, K. C., Jena, M. K., Pradhan, B. S., Nayak, N., Das, S., Hsu, C.-D., Wheeler, D. S., Chen, K., & Nayak, N. R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191040 · Cited by 258
Mechanisms of lncRNA/microRNA interactions in angiogenesis
Zhao, Z., Sun, W., Guo, Z., Zhang, J., Yu, H., & Liu, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2019.116900 · Cited by 262
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Ahmad, R., Singh, J., Wunnava, A., Al‑Obeed, O., Abdulla, M., & Srivastava, S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4847 · Cited by 189
Zhao, Y., Guo, S., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Chen, M., Li, X., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70958 · Cited by 246
“PIP3 induces serine/threonine-specific protein kinase (AKT) phosphorylation, which activates endothelial nitric oxide synthase (eNOS) to produce nitric oxide (NO) and induces endothelial cell proliferation and migration [27, 28] (Figure 1).”
BackgroundAngiogenesis in Breast Cancer Progression, Diagnosis, and Treatment
Madu, C. O., Wang, S., Madu, C. O., & Lu, Y. (2020) · Journal of Cancer · doi:10.7150/jca.44313 · Cited by 249
Cell–matrix signals specify bone endothelial cells during developmental osteogenesis
Langen, U. H., Pitulescu, M. E., Kim, J. M., Enriquez-Gasca, R., Sivaraj, K. K., Kusumbe, A. P., Singh, A., Di Russo, J., Bixel, M. G., Zhou, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3476 · Cited by 254
Li, H., Xue, K., Kong, N., Liu, K., & Chang, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.039 · Cited by 257
“Our study here demonstrated that the involvement of CS further enhanced the paracrine effect by upregulating VEGF in co-HBMSCs, which further exerted its effects by binding to its receptors KDR in co-HUVECs and the KDR plays essential roles in VEGF induced angiogenesis [40].”
BackgroundActivation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis
Larrivée, B., Freitas, C., Trombe, M., Lv, X., DeLafarge, B., Yuan, L., Bouvrée, K., Bréant, C., Del Toro, R., Bréchot, N., et al. (2007) · Genes & Development · doi:10.1101/gad.437807 · Cited by 239
“These endothelial tip cells guide outgrowing capillaries in response to gradients of extracellular matrix-bound vascular endothelial growth factor (VEGF) (Gerhardt et al. 2003; Olsson et al. 2006; Shibuya 2006).”
BackgroundVEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
Giacca, M., & Zacchigna, S. (2012) · Gene Therapy · doi:10.1038/gt.2012.17 · Cited by 252
Anticancer strategies involving the vasculature
Heath, V. L., & Bicknell, R. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.52 · Cited by 255
“VEGF A is the predominant mediator of angiogenesis in tumors”
BackgroundVascular endothelial growth factor receptor-2 in breast cancer
Guo, S., Colbert, L. S., Fuller, M., Zhang, Y., & Gonzalez-Perez, R. R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.04.004 · Cited by 246
“Signaling through mitogen-activated protein-kinase (MAP; including MEK-p42/p44 MAPK and p38 MAPK; linked to proliferation) [40,46] and phosphatidylinositol 3′ kinase (PI-3K)/V-akt murine thymoma viral oncogene homolog 1 (Akt1; linked to survival) [47] are common receptor tyrosine kinase activation patterns.”
BackgroundInfluentialAge‐Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
Hernández-Zimbrón, L. F., Zamora-Alvarado, R., Ochoa-De la Paz, L., Velez-Montoya, R., Zenteno, E., Gulias-Cañizo, R., Quiroz-Mercado, H., & Gonzalez-Salinas, R. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8374647 · Cited by 240
“The VEGF-A’s biological activity is dependent on proteolytic processes; the products obtained from this degradation interact differentially with VEGF-R1 and VEGF-R2 receptors [8].”
BackgroundChamorro-Jorganes, A., Araldi, E., Penalva, L. O. F., Sandhu, D., Fernández-Hernando, C., & Suárez, Y. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.236521 · Cited by 240
Masoumi Moghaddam, S., Amini, A., Morris, D. L., & Pourgholami, M. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9337-5 · Cited by 228
“VEGF, VEGF-B, and PlGF can bind and activate VEGFR-1, whereas VEGFR-2 is primarily activated by VEGF, and VEGFR-3 activation is only triggered by VEGF-C and VEGF-D [24].”
BackgroundInfluentialVascular endothelial growth factor and diabetic complications
WIROSTKO, B., WONG, T., & SIMO, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241
Targeting VEGF-A to Treat Cancer and Age-Related Macular Degeneration
Ferrara, N., Mass, R. D., Campa, C., & Kim, R. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145635 · Cited by 238
Merino-González, C., Zuñiga, F. A., Escudero, C., Ormazabal, V., Reyes, C., Nova-Lamperti, E., Salomón, C., & Aguayo, C. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00024 · Cited by 238
“Proteomic analysis showed that exosomes derived from MSCs contain growth factors such as VEGF, TGFB1, and interleukin-8 (IL-8), which have been shown to contribute in their pro-angiogenic activity (Coultas et al., 2005; Olsson et al., 2006).”
MethodSignal transduction in vasculogenesis and developmental angiogenesis
Patel-Hett, S., & DAmore, P. A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103213sp · Cited by 228
“PI3K activates the Akt/PKB pathway, which mediates endothelial cell survival (Dayanir et al., 2001; Fujio and Walsh, 1999; Olsson et al., 2006) and vascular permeability through its activation of endothelial nitric oxide synthase (eNOS) (Fukumura et al.”
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Venuraju, S. M., Yerramasu, A., Corder, R., & Lahiri, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.013 · Cited by 237
“Vascular ndothelial growth factor induces endothelial cell prolifertion, survival, and migration, resulting in the formation of vascular network supplying oxygen and nutrients for urther development (6).”
BackgroundYi, T., Yi, Z., Cho, S.-G., Luo, J., Pandey, M. K., Aggarwal, B. B., & Liu, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5944 · Cited by 237
“Major autophosphorylation sites on VEGFR2 have been described as Y(1175) and Y(951)(15).”
BackgroundInfluentialRecent therapeutic trends and promising targets in triple negative breast cancer
Hwang, S.-Y., Park, S., & Kwon, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.006 · Cited by 232
Wang, Z., Wang, N., Han, S., Wang, D., Mo, S., Yu, L., Huang, H., Tsui, K., Shen, J., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068566 · Cited by 233
“such as Asn921, Cys1043, Arg1030 and Asn1031 [45,46].”
Cyclic Stretch, Reactive Oxygen Species, and Vascular Remodeling
Birukov, K. G. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2390 · Cited by 227
“Hypertrophic effects of ROS on the vasculature are associated with ROS-induced of c-Src, which in turn transactivates receptor tyrosine kinases EGF-R and PDGF-R.”
InfluentialPartitioning the heart: mechanisms of cardiac septation and valve development
Lin, C.-J., Lin, C.-Y., Chen, C.-H., Zhou, B., & Chang, C.-P. (2012) · Development · doi:10.1242/dev.063495 · Cited by 218
Axl is essential for VEGF‐A‐dependent activation of PI3K/Akt
Ruan, G., & Kazlauskas, A. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.21 · Cited by 223
“The PI3K/Akt pathway is essential for several VEGF-A-induced cellular responses including cell migration, permeability and tube formation (Olsson et al , 2006).”
InfluentialDevelopment and Function of the Blood-Brain Barrier in the Context of Metabolic Control
Haddad-Tóvolli, R., Dragano, N. R. V., Ramalho, A. F. S., & Velloso, L. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00224 · Cited by 226
“Downstream VEGF signaling supports angiogenesis through endothelial cell proliferation, migration and survival (Olsson et al., 2006).”
BackgroundMarkowska, A. I., Jefferies, K. C., & Panjwani, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226423 · Cited by 218
Payen, V. L., Porporato, P. E., Baselet, B., & Sonveaux, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2098-5 · Cited by 220
Inflammation balance in skeletal muscle damage and repair
Tu, H., & Li, Y.-L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133355 · Cited by 197
“When the muscle trauma results in the disruption of blood flow and reduction of oxygen, hypoxia inducible factor (HIF) is elevated in the injured muscle, which induces the production and release of VEGF from macrophages to bind to VEGF receptors (VEGFR) expressed in endothelial cells for the proliferation, migration,…”
BackgroundBreen, E. C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21579 · Cited by 220
“The first clue that VEGFmay play a role in neuronal cells came from the identification of the VEGF co-receptors, neuropilins, which bind both VEGF and several members of the semaphorin family of proteins involved in axon guidance [Olsson et al., 2006].”
Vascular morphogenesis in the zebrafish embryo
Ellertsdóttir, E., Lenard, A., Blum, Y., Krudewig, A., Herwig, L., Affolter, M., & Belting, H.-G. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.10.035 · Cited by 219
Exercise‐Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF
Hoier, B., & Hellsten, Y. (2014) · Microcirculation · doi:10.1111/micc.12117 · Cited by 215
“In skeletal muscle tissue, VEGFR-2 has been described to be the most important for angiogenesis whereas the role of VEGFR-1 is less defined [95,104].”
BackgroundSuperTarget goes quantitative: update on drug-target interactions
Hecker, N., Ahmed, J., von Eichborn, J., Dunkel, M., Macha, K., Eckert, A., Gilson, M. K., Bourne, P. E., & Preissner, R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr912 · Cited by 213
“Pathways, which include Vascular Endothelial Growth Factors (VEGF), play an important role in angiogenesis and provide targets for anti-angiogenic cancer therapy (27).”
BackgroundIncreased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones
Maes, C., Goossens, S., Bartunkova, S., Drogat, B., Coenegrachts, L., Stockmans, I., Moermans, K., Nyabi, O., Haigh, K., Naessens, M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.361 · Cited by 212
“Although this pharmacological experiment ruled out cell specificity, the central role of the PI3-kinase pathway in VEGF/VEGFR-2 signal transduction in endothelial cells—mediating primarily cell survival and migration—is very well established (Olsson et al, 2006).”
BackgroundTargeting tumors with nanobodies for cancer imaging and therapy
Oliveira, S., Heukers, R., Sornkom, J., Kok, R. J., & van Bergen en Henegouwen, P. M. P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.298 · Cited by 206
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jászai, J., & Schmidt, M. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 208
“This substantially modifies the spreading and biological availability of certain members of this secreted growth factor family [14,15,79, 90,95,96].”
BackgroundCharacterization of Uptake and Internalization of Exosomes by Bladder Cancer Cells
Franzen, C. A., Simms, P. E., Van Huis, A. F., Foreman, K. E., Kuo, P. C., & Gupta, G. N. (2014) · BioMed Research International · doi:10.1155/2014/619829 · Cited by 204
“We next determined if exosome uptake could be inhibited with heparin, a competitive inhibitor of cell surface receptors dependent on Heparan Sulfate Proteoglycan (HSPG) coreceptors [19–21], including Syndecan, an HSPG shown to be important for exosome biogenesis [22].”
BackgroundThe spatiotemporal development of adipose tissue
Han, J., Lee, J.-E., Jin, J., Lim, J. S., Oh, N., Kim, K., Chang, S.-I., Shibuya, M., Kim, H., & Koh, G. Y. (2011) · Development · doi:10.1242/dev.067686 · Cited by 212
“…and VEGFR3 (FLT4) are specific 5033RESEARCH ARTICLEDevelopment of adipose tissue D E V E LO P M E N T 5034 receptors for these two respective ligands (Olsson et al., 2006; Adams and Alitalo, 2007), we examined the expression pattern of VEGFR2 and VEGFR3 in the growing vascular networks of EAT.”
BackgroundRegulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin
Kitamura, T., Asai, N., Enomoto, A., Maeda, K., Kato, T., Ishida, M., Jiang, P., Watanabe, T., Usukura, J., Kondo, T., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1695 · Cited by 212
Huang, S.-C., Zhang, L., Sung, Y.-S., Chen, C.-L., Kao, Y.-C., Agaram, N. P., Singer, S., Tap, W. D., D’Angelo, S., & Antonescu, C. R. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000582 · Cited by 206
Liu, H., Liu, S., Qiu, X., Yang, X., Bao, L., Pu, F., Liu, X., Li, C., Xuan, K., Zhou, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1717128 · Cited by 209
Wu, F. T. H., Stefanini, M. O., Gabhann, F. M., Kontos, C. D., Annex, B. H., & Popel, A. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00941.x · Cited by 203
“VEGF-A binding to VEGFR1 is generally considered anti-angiogenic – possibly due to sequestration of VEGF-A which lowers its availability for VEGFR2 activation, although direct intracellular signal transduction has not been ruled out [31, 46–48].”
BackgroundInfluentialNew Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease
Annex, B. H., & Cooke, J. P. (2021) · Circulation Research · doi:10.1161/circresaha.121.318266 · Cited by 200
Roles of VEGF-A signalling in development, regeneration, and tumours
Matsumoto, K., & Ema, M. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu031 · Cited by 198
Qian, B.-Z., Zhang, H., Li, J., He, T., Yeo, E.-J., Soong, D. Y. H., Carragher, N. O., Munro, A., Chang, A., Bresnick, A. R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141555 · Cited by 198
“FLT1 is a family member of VEGF receptor (VEGFR) transmem brane receptor tyrosine kinases that binds to VEGF and pla cental growth factor (PlGF; Olsson et al., 2006).”
BackgroundGremlin is a novel agonist of the major proangiogenic receptor VEGFR2
Mitola, S., Ravelli, C., Moroni, E., Salvi, V., Leali, D., Ballmer-Hofer, K., Zammataro, L., & Presta, M. (2010) · Blood · doi:10.1182/blood-2010-06-291930 · Cited by 202
Maharaj, A. S. R., & D'Amore, P. A. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.03.004 · Cited by 195
“However, VEGF may act on other cell types based on the presence of either VEGFR1 or VEGFR2 on those cells.”
BackgroundInfluentialDriving Rho GTPase activity in endothelial cells regulates barrier integrity
Beckers, C., van Hinsbergh, V., & van Nieuw Amerongen, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0403 · Cited by 209
“Interestingly, in tumor ECs lacking associated pericytes VEGFmediated Tyr951 phosphorylation of VEGFR2 binds TSAd (T-cellspecific adapter molecule) which is required for SF formation and motility (133), suggesting that this pathway is involved in RhoA activation.”
BackgroundHazarika, S., Dokun, A. O., Li, Y., Popel, A. S., Kontos, C. D., & Annex, B. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.160630 · Cited by 202
Zentilin, L., Puligadda, U., Lionetti, V., Zacchigna, S., Collesi, C., Pattarini, L., Ruozi, G., Camporesi, S., Sinagra, G., Pepe, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-143180 · Cited by 200
“migration, and survival of endothelial cells (4, 5).”
BackgroundVEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
Zhang, Z., Neiva, K. G., Lingen, M. W., Ellis, L. M., & Nör, J. E. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.152 · Cited by 197
“The VEGF receptors, VEGFR1 and VEGFR2, are structurally related members of the receptor tyrosine kinase (RTK) family that mediate critical signaling pathways in endothelial cells (12-14).”
Sela, S., Itin, A., Natanson-Yaron, S., Greenfield, C., Goldman-Wohl, D., Yagel, S., & Keshet, E. (2008) · Circulation Research · doi:10.1161/circresaha.108.171504 · Cited by 194
Green tea and its anti-angiogenesis effects
Rashidi, B., Malekzadeh, M., Goodarzi, M., Masoudifar, A., & Mirzaei, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.161 · Cited by 197
Proliferation, behavior, and differentiation of osteoblasts on surfaces of different microroughness
Andrukhov, O., Huber, R., Shi, B., Berner, S., Rausch-Fan, X., Moritz, A., Spencer, N. D., & Schedle, A. (2016) · Dental Materials · doi:10.1016/j.dental.2016.08.217 · Cited by 192
Chapouly, C., Tadesse Argaw, A., Horng, S., Castro, K., Zhang, J., Asp, L., Loo, H., Laitman, B. M., Mariani, J. N., Straus Farber, R., et al. (2015) · Brain · doi:10.1093/brain/awv077 · Cited by 190
“VEGFA exerts its effects on CMVEC via activation of the receptor tyrosine kinase VEGFR2/KDR/Flk-1 (Olsson et al., 2006).”
BackgroundInfluentialEndothelial-Specific Cre Mouse Models: Is Your Cre CREdibile?
Payne, S., De Val, S., & Neal, A. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.309669 · Cited by 196
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
Veron, D., Reidy, K. J., Bertuccio, C., Teichman, J., Villegas, G., Jimenez, J., Shen, W., Kopp, J. B., Thomas, D. B., & Tufro, A. (2010) · Kidney International · doi:10.1038/ki.2010.64 · Cited by 197
Disorders of Vascular Permeability
Park-Windhol, C., & D'Amore, P. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044506 · Cited by 190
“VEGF interacts with both VEGFR1 and -R2, but only VEGFR2 is directly involved in normal and pathological vascular permeability (57).”
BackgroundInhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
Liu, G., Chen, T., Ding, Z., Wang, Y., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13009 · Cited by 189
Hantavirus regulation of endothelial cell functions
Gavrilovskaya, I., & Mackow, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-09-0640 · Cited by 191
HIFs, angiogenesis, and cancer
Yang, Y., Sun, M., Wang, L., & Jiao, B. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24438 · Cited by 191
“Deletion of HIF-1a in ECs disrupted an autocrine loop necessary for hypoxic induction of both VEGFR-1 and VEGFR-2 by VEGF signaling [Olsson et al., 2006].”
BackgroundJin, Y., Muhl, L., Burmakin, M., Wang, Y., Duchez, A.-C., Betsholtz, C., Arthur, H. M., & Jakobsson, L. (2017) · Nature Cell Biology · doi:10.1038/ncb3534 · Cited by 192
“Inhibition of VEGFR2 or PI(3)K signalling reduces the severity of Eng LOF-mediated AVM To test the relevance of altered VEGFR2 activity and downstream signalling on the development of AVM in vivo, the VEGFR2 kinase inhibitor SU5416 or the phosphoinositide 3-kinase (PI(3)K)–AKT inhibitor wortmannin was administered dai…”
BackgroundMethodInfluentialVEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 188
“VEGFR2, VEGFR2 mainly mediates VEGF signaling in endothelial cells (Takahashi and Shibuya 2005; Olsson et al. 2006).”
BackgroundRuan, G.-X., & Kazlauskas, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474619 · Cited by 181
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.30 · Cited by 184
“These ligands bind in an overlapping pattern to three different receptor tyrosine kinases denoted VEGF receptor 1 (VEGFR1), VEGFR2 and VEGFR3 (Olsson et al, 2006).”
BackgroundSelf-citationToward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration
Tejero, R., Anitua, E., & Orive, G. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.01.001 · Cited by 187
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
Vecchione, A., Belletti, B., Lovat, F., Volinia, S., Chiappetta, G., Giglio, S., Sonego, M., Cirombella, R., Onesti, E. C., Pellegrini, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305472110 · Cited by 188
“In fact, miR-484, according to different prediction algorithms, targets the VEGFB, which is able to directly stimulate endothelial cell growth and migration (15), and the VEGFR2/KDR, which is implicated in all aspects of normal and pathological vascular endothelial cell biology (16).”
BackgroundOrai1 and CRAC Channel Dependence of VEGF-Activated Ca 2+ Entry and Endothelial Tube Formation
Li, J., Cubbon, R. M., Wilson, L. A., Amer, M. S., McKeown, L., Hou, B., Majeed, Y., Tumova, S., Seymour, V. A. L., Taylor, H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243352 · Cited by 183
Mechanisms of resistance to antiangiogenesis therapy
Azam, F., Mehta, S., & Harris, A. L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.020 · Cited by 178
Guo, X., Yi, H., Li, T. C., Wang, Y., Wang, H., & Chen, X. (2021) · Biomolecules · doi:10.3390/biom11020253 · Cited by 172
Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema
Lähteenvuo, M., Honkonen, K., Tervala, T., Tammela, T., Suominen, E., Lähteenvuo, J., Kholová, I., Alitalo, K., Ylä-Herttuala, S., & Saaristo, A. (2011) · Circulation · doi:10.1161/circulationaha.110.965384 · Cited by 184
“VEGFR activation promotes cell proliferation, migration, and survival (Olsson et al. 2006).”
BackgroundRole of hypoxia-inducible factor-1α in angiogenic–osteogenic coupling
Riddle, R. C., Khatri, R., Schipani, E., & Clemens, T. L. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0477-9 · Cited by 186
“VEGF family members, including VEGFA, VEGF-B, VEGF-C, VEGF-D, and placenta growth factor, are secreted, dimeric glycoproteins that activate one of three receptor tyrosine kinases [19].”
BackgroundWheeler, G. N., & Brändli, A. W. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21967 · Cited by 170
“Positive hits included inhibitors of the VEGF signaling pathway, which is essential for vascular development (Olsson et al., 2006), and thus validates the in vivo chemical screening approach.”
BackgroundInhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function
Jean, C., Chen, X. L., Nam, J.-O., Tancioni, I., Uryu, S., Lawson, C., Ward, K. K., Walsh, C. T., Miller, N. L. G., Ghassemian, M., et al. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201307067 · Cited by 176
“VEGF-A, via the binding to a VEGF receptor (VEGFR-2) on ECs (Olsson et al., 2006), triggers rapid VEC tyrosine (Y) phosphorylation and results in VEC–-catenin–p120-catenin– -catenin complex dissociation (Potter et al., 2005) and increased vascular permeability.”
Franzen, C. A., Blackwell, R. H., Todorovic, V, Greco, K. A., Foreman, K. E., Flanigan, R. C., Kuo, P. C., & Gupta, G. N. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.21 · Cited by 182
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Yu, S. M.-W., & Bonventre, J. V. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.005 · Cited by 175
The VEGF family in cancer and antibody-based strategies for their inhibition
Sullivan, L. A., & Brekken, R. A. (2010) · mAbs · doi:10.4161/mabs.2.2.11360 · Cited by 181
Manetti, M., Guiducci, S., Romano, E., Ceccarelli, C., Bellando-Randone, S., Conforti, M. L., Ibba-Manneschi, L., & Matucci-Cerinic, M. (2011) · Circulation Research · doi:10.1161/circresaha.111.242057 · Cited by 178
Dehghani, S., Nosrati, R., Yousefi, M., Nezami, A., Soltani, F., Taghdisi, S. M., Abnous, K., Alibolandi, M., & Ramezani, M. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.03.037 · Cited by 181
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
Grimminger, F., Günther, A., & Vancheri, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00149614 · Cited by 178
The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development
Kazanskaya, O., Ohkawara, B., Heroult, M., Wu, W., Maltry, N., Augustin, H. G., & Niehrs, C. (2008) · Development · doi:10.1242/dev.027284 · Cited by 173
“VEGF plays a central role in many aspects of vascular development and embryonic angiogenesis (Carmeliet et al., 1996; Ferrara et al., 1996; Coultas et al., 2005) (reviewed by Ferrara, 1999; Tammela et al., 2005; Olsson et al., 2006).”
BackgroundGavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A., & Mackow, E. R. (2008) · Journal of Virology · doi:10.1128/jvi.02397-07 · Cited by 175
“Endothelial cells contain VEGFR2 receptors (Flk-1), which mediate migrational responses of endothelial cells to VEGF (50).”
BackgroundRedox regulation of protein kinases
Truong, T. H., & Carroll, K. S. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.790873 · Cited by 169
“A wide range of diseases including chronic inflammation, vascular ischemia, and atherosclerosis have been linked to angiogenesis (Olsson et al., 2006).”
Kunizaki, M., Hamamoto, R., Silva, F. P., Yamaguchi, K., Nagayasu, T., Shibuya, M., Nakamura, Y., & Furukawa, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1132 · Cited by 169
“VEGFR1 contains phosphorylated tyrosines, including tyrosines 1169, 1213, 1242, 1327, and 1333 ( 20 ), and it remains unresolved which tyrosine(s) phosphorylation is enhanced by the methylation.”
BackgroundVascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Georganaki, M., van Hooren, L., & Dimberg, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03081 · Cited by 172
“Downstream of VEGFR2 activation, multiple intracellular pathways are induced that regulate cell division, survival, sprouting, and migration of endothelial cells (30).”
BackgroundSelf-citationc-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
Gao, F.-Y., Li, X.-T., Xu, K., Wang, R.-T., & Guan, X.-X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01043-1 · Cited by 167
Recent synthetic and medicinal perspectives of tryptanthrin
Kaur, R., Manjal, S. K., Rawal, R. K., & Kumar, K. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.003 · Cited by 177
“Vascular endothelial growth factor receptor 2 (VEGFR2) is the primary receptor of VEGF and the major mediator of VEGFinduced pro-angiogenesis signaling in endothelial cells.(57,58) The anti-angiogenic effect of tryptanthrin was demonstrated for the first time using the human microvascular endothelial HMEC-1 cells.”
BackgroundNiu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 170
“VEGF isoforms can also interact with the neuropilin co-receptors (NRP1 and NRP2).(139,140) During tumorigenesis, angiogenesis plays a key role in maintaining the expansion in tumor.”
BackgroundReceptor Tyrosine Kinase-Mediated Angiogenesis
Jeltsch, M., Leppanen, V.-M., Saharinen, P., & Alitalo, K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 175
“1)—are largely restricted to the ECs in vertebrates, although they also are expressed in a few other cell types, notably in some hematopoietic cells (listed in the supplementary information S2 in Olsson et al. 2006).”
BackgroundCardiomyocyte—Endothelial Cell Interactions in Cardiac Remodeling and Regeneration
Talman, V., & Kivelä, R. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00101 · Cited by 171
“The main cardiokine regulating EC activation and proliferation is vascular endothelial growth factor (VEGF) that binds to and activates the VEGF receptor 2 (VEGFR2, also known as KDR and FLK1) in ECs (34).”
BackgroundSystems Biology of Vascular Endothelial Growth Factors
GABHANN, F. M., & POPEL, A. S. (2008) · Microcirculation · doi:10.1080/10739680802095964 · Cited by 162
“Several excellent reviews on the multiple signaling pathways induced by VEGF through its receptors are available [113,136,173,178].”
BackgroundSchnell, C. R., Stauffer, F., Allegrini, P. R., O'Reilly, T., McSheehy, P. M. J., Dartois, C., Stumm, M., Cozens, R., Littlewood-Evans, A., García-Echeverría, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1044 · Cited by 174
“The phosphatidylinositol 3-kinase (PI3K) pathway is of relevance for VEGF-induced endothelial signaling (6).”
Background
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.